$SWISF $SKUR.C Sekur Private Data Ltd. Signs Distribution

New Post Public Reply Private Reply Replies (0) Message Board
louied91
255
$SWISF $SKUR.C Sekur Private Data Ltd. Signs Distribution Agreement with VYRE Network - Reaching over 1 million Global Streamers for Its Sekur Privacy Communications Solutions


https://www.newsfilecorp.com/release/180317

Toronto, Ontario and New York, New York--(Newsfile Corp. - September 12, 2023) - Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0) ("Sekur" or the "Company" , a leading Swiss hosted secure and private communications platform, is pleased announce that it has signed a distribution agreement with VYRE Network ("VYRE" (OTC:CAPV), specifically its VBNGtv channel, a leading news-based streaming channel and website, to feature and distribute the Company's Sekur suite of privacy communications solutions, including the upcoming Sekur Enterprise solutions.

The distribution agreement gives Sekur access to well over 1 million VYRE Network streaming viewers worldwide, with specific focus on VYRE Business News Global ("VBNGtv" and its growing community of seasoned investors, CEO's, CIOs, CFOs, and C-Suite Executives. Sekur video commercials and programmatic banner ads will be placed in various places on the VBNGtv website, giving a maximum exposure to Sekur's suite of privacy communications solutions, and a revenue share shall be given to VYRE for each purchase of any Sekur solution.

VBNGtv is a Television Streaming Channel subsidiary of VYRE Network and has global distribution through the VYRE App & Web for TV News shows, Documentaries, Interviews and Business focused entertainment content. Currently, the VYRE App is downloaded in 186 countries and is distributed in the following platforms: Apple TV, iPhone, Android, Samsung, Hisense TV, Roku TV, Amazon Fire Stick, Tizen TV, Xbox, and the Web. VBNGtv is comprised of Journalists that are forward-thinking and technologically savvy, who are committed to delivering informal video & editorial content brands to targeted audiences.

VBNGtv provides generative storytelling, and data analysis with integrated AI technology in the USA, Europe, Middle East, Australia, Asia, Central/South America, Africa markets available to fuel campaigns. VBNGtv can be seen at the following website https://vbngtv.com.

"We are looking forward to working with the team at Sekur and being able to provide our users on the VYRE Business News Global channel with the opportunity to preview this technology," stated David Hill, CEO of VYRE Network.

Alain Ghiai, CEO of Sekur Private Data said: "We are very excited to have completed the partnership with VYRE, as this expands our reach to well over 1.1 million users who downloaded the VYRE App to date. Having access to C-Suite executives gives Sekur and the upcoming Sekur Enterprise solutions, a large exposure to a new audience covering 186 countries. VBNGtv is a perfect place for us to promote Sekur to a professional audience and C-level executives, as well as potential investors looking to protect their data and privacy. Our Sekur privacy solutions are used more and more by professionals, and the VBNGtv partnership is part of that launch strategy to launch our SMB and Enterprise solutions in the USA to the 30 million+ small businesses in the USA. This is where Sekur comes in, to ensure private and secure communications and prevent Business Email Compromise ("BEC" attacks with our SekurSend feature on SekurMail, and to offer a private and secure alternative to data mined messaging applications, with our SekurMessenger and our Chat by Invite unique privacy function. We will also offer our SekurVPN as there is a growing market demand for VPNs. Our prime directive is to provide private and secure communications for everyone, and, as we are not connected to any Big Tech cloud platform, we offer a truly independent, private and secure means of communications without any data mining, through our proprietary technology and our secure servers based in Switzerland. We look forward to offering true data privacy to all businesses and government organizations, and protect their intellectual property and privacy, from data miners, malicious hackers and rogue agents of foreign powers."

On April 7th 2023, the Company launched its privacy VPN solution called SekurVPN available through https://www.sekur.com. The Company has seen great success for SekurVPN for consumers, and plans to market to the SMB and enterprise in Q4, targeting the 30 million SMBs in the USA, through several digital and email marketing campaigns.

SekurVPN is meant for privacy enthusiasts and users wanting to mask their IP address and protect their Internet activities from hackers, rogue agents and industrial spies. An example would be users going to their e-banking or shopping online, using their emails, using messaging applications and wanting to have full privacy and protection from hackers hijacking their location and signal. The service guarantees that it does not use Big Tech or Hyperscalers for its functioning or hosting, it guarantees that there are no third party bundles sold with it, so no data is leaked or sold to third parties, it guarantees no traffic pulling or monitoring, and no phone number required to register to the service. Using a private VPN such as SekurVPN can reduce greatly the risk of BEC attacks for C-Level enterprise employees.

According to a study and publication on forbes.com, 66% use a VPN to help protect personal data, 80% use a VPN for increased security and 33% use a VPN to mask their internet activity. More statistics can be found on this VPN Statistics And Trends In 2023 article.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Expanding Horizons: Future of IVD Contract Manufacturing

Updated Category News Views 117

The Growing Landscape of IVD Contract Manufacturing The in vitro diagnostics (IVD) contract manufacturing market is on the brink of significant expansion, anticipated to reach a staggering USD 39.74 billion by 2031. This growth represents a compounded annual growth rate (CAGR) of 11.60% from 2024 to 2031, driven chiefly by the needs of the healthcare industry to keep pace...

Continue Reading
Citi Upgrades AerCap Holdings Price Target to $117 Amid Strong Performance

Updated Category News Views 79

Citi Upgrades AerCap Holdings Price Target Citi has recently updated its outlook on AerCap Holdings (NYSE:AER), raising the price target to $117 from $113. This move reflects Citi's confident stance on the aircraft leasing company's financial health within the aviation sector. By reaffirming their buy rating, the firm signals strong expectations for AerCap's growth...

Continue Reading
LG Energy Solution Reports Strong Q2 2025 Financial Performance

Updated Category News Views 750

LG Energy Solution Achieves Remarkable Financial Milestones In a significant announcement, LG Energy Solution has revealed its performance for the second quarter of 2025, detailing impressive results that demonstrate the company's resilience and strategic focus on growth. With consolidated revenue of KRW 5.6 trillion and an operating profit of KRW 492.2 billion, the...

Continue Reading
Genpact Shines as a Leader in Sustainability Recognition

Updated Category News Views 264

Genpact's Sustainable Initiatives Gain Global Recognition Recently, Genpact (NYSE: G), an advanced technology services provider, received significant acclaim for its commitment to sustainability. Being featured in TIME's prestigious list of the World's Best Companies in Sustainable Growth for 2025 showcases their dedication to ethical business practices and innovation. A...

Continue Reading
Medical Express Ambulance Faces Data Breach Investigation

Updated Category News Views 344

Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....

Continue Reading